Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREV-AF: Atrial Fibrillation Prevention After Cardiac Surgery
NCT07887022Phase 3Not yet recruiting
- Sponsor
- Elsan
- Start
- Jan 2027
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine, amiodarone in Atrial fibrillation (AFib), sponsored by Elsan. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
colchicineamiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07887022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07887022.